BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oliver J, Garcia-Aranda M, Chaves P, Alba E, Cobo-Dols M, Onieva JL, Barragan I. Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction. Semin Cancer Biol 2021:S1044-579X(21)00062-6. [PMID: 33757849 DOI: 10.1016/j.semcancer.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
2 Chen S, Duan H, Zhang D, Sun G, Li T. Correlation between RASSF1A Methylation in Cell-Free DNA and the Prognosis of Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/3458420] [Reference Citation Analysis]
3 Rogozin IB, Roche-Lima A, Tyryshkin K, Carrasquillo-Carrión K, Lada AG, Poliakov LY, Schwartz E, Saura A, Yurchenko V, Cooper DN, Panchenko AR, Pavlov YI. DNA Methylation, Deamination, and Translesion Synthesis Combine to Generate Footprint Mutations in Cancer Driver Genes in B-Cell Derived Lymphomas and Other Cancers. Front Genet 2021;12:671866. [PMID: 34093666 DOI: 10.3389/fgene.2021.671866] [Reference Citation Analysis]
4 Ling C. Pharmacoepigenetics in type 2 diabetes: is it clinically relevant? Diabetologia. [DOI: 10.1007/s00125-022-05681-x] [Reference Citation Analysis]